Dr. Fehrenbacher received a B.S. from the University of Southern Indiana in 1999 and a Ph.D. from Indiana University in 2005. She completed her postdoctoral fellowship in the Department of Endodontics at the University of Texas Health Science Center in San Antonio. In 2010, she joined Indiana University as an Assistant Professor with a primary appointment in the Department of Pharmacology and Toxicology and as a member of the Stark Neurosciences Research Institute.
An internationally respected expert in physical and psychological symptoms, Dr. Kurt Kroenke’s principal research interests include pain, depression, anxiety and other symptoms without discernible cause. Dr. Kroenke has developed multiple patient-reported outcome measures which have been translated into 100 or more languages and used globally, including the PHQ-9 depression scale, GAD-7 anxiety scale, PHQ-15 somatization scale, PEG pain scale, and P4 suicidality screener. The PHQ-9 and GAD-7 are now used by the Centers for Medicare and Medicaid Services, VA, Food and Drug Administration, as national guidelines, in electronic health records, and in scores of research and clinical practice settings.
Dr. Mosher is an associate professor of psychology at Indiana University-Purdue University Indianapolis (IUPUI). Since 2010, she has been directing the Behavioral Oncology laboratory. She has a Ph.D. in clinical psychology from SUNY Albany, and she has completed postdoctoral training in psycho-oncology at Memorial Sloan-Kettering Cancer Center. Her primary research interests are: (1) developing, evaluating, and disseminating psychosocial interventions for cancer patients and their family caregivers; and (2) identifying demographic, medical, and social predictors of physical and psychological health outcomes in cancer patients and their family caregivers. Her recent projects have focused on novel applications of Acceptance and Commitment Therapy for these populations.